Bisphosphonate-related osteonecrosis of the jaw in non-malignant bone disease

被引：4
|
作者：
Wong, Peter K. [1 ,2 ]
Borromeo, Gelsomina L. [3 ]
Wark, John D. [4 ,5 ]
机构：
[1] Midnorth Coast Arthrit Clin, Coffs Harbour, NSW 2450, Australia
[2] Univ New S Wales, Rural Clin Sch, Fac Med, Kensington, NSW 2033, Australia
[3] Univ Melbourne, Melbourne Dent Sch, Melbourne, Vic, Australia
[4] Univ Melbourne, Dept Med, Melbourne, Vic 3052, Australia
[5] Royal Melbourne Hosp, Melbourne, Vic, Australia
来源：
RHEUMATOLOGY INTERNATIONAL | 2013年 / 33卷 / 09期
关键词：
Bisphosphonate; Osteonecrosis; Jaw; Non-malignant; Bone; OF-THE-LITERATURE; ZOLEDRONIC-ACID; RISK-FACTORS; MULTIPLE-MYELOMA; AMERICAN ASSOCIATION; ORAL BISPHOSPHONATES; POSTMENOPAUSAL WOMEN; PREVENTIVE MEASURES; AVASCULAR NECROSIS; CLINICAL-FEATURES;
D O I：
10.1007/s00296-013-2771-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Bisphosphonates such as alendronate, risedronate and zoledronate have revolutionised the treatment for osteoporosis and Paget's disease. These drugs reduce fracture risk and probably mortality in patients with osteoporosis. However, they have a long in vivo half-life following cessation and may be associated with delayed dental healing and even the devastating complication of osteonecrosis of the jaw (ONJ). Extensive media attention highlighting this issue has caused much concern among patients and healthcare professionals. This paper seeks to provide treating clinicians with a balanced multi-disciplinary review of the available evidence pertaining to this issue and practical advice regarding prevention and management of ONJ.
引用
收藏
页码：2189 / 2198
页数：10
相关论文
共 50 条
  • [21] Bisphosphonate-Related Osteonecrosis of the Jaw in Patients with Osteoporosis
    Heng, Christine
    Badner, Victor M.
    Vakkas, Tasios G.
    Johnson, Rosemary
    Yeo, Yvon
    AMERICAN FAMILY PHYSICIAN, 2012, 85 (12) : 1134 - +
  • [22] CELL THERAPY IN BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAW
    Iovan, Gianina
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2013, 117 (03): : 788 - 788
  • [23] Histomorphologic characteristics of bisphosphonate-related osteonecrosis of the jaw
    Koerdt, Steffen
    Dax, Svenja
    Grimaldi, Hannes
    Ristow, Oliver
    Kuebler, Alexander C.
    Reuther, Tobias
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2014, 43 (06) : 448 - 453
  • [24] Refinements in the reconstruction of bisphosphonate-related osteonecrosis of the jaw ?
    Maeda, Taku
    Yamamoto, Yuhei
    Satoh, Akira
    Hayashi, Toshihiko
    JPRAS OPEN, 2023, 35 : 1 - 5
  • [25] A cutaneous presentation of bisphosphonate-related osteonecrosis of the jaw
    McCusker, S.
    May, C.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2020, 45 (07) : 932 - 934
  • [26] Bisphosphonate-Related Osteonecrosis of the Jaw: Tip of the Iceberg
    Knight, Robert John W.
    Reddy, Chaithan
    Rtshiladze, Michael A.
    Lvoff, Gregory
    Sherring, David
    Marucci, Damian
    JOURNAL OF CRANIOFACIAL SURGERY, 2010, 21 (01) : 25 - 32
  • [27] Bisphosphonate-Related Osteonecrosis of the Jaw: A Review of the Literature
    Sigua-Rodriguez, Eder Alberto
    Ribeiro, Renato da Costa
    Ramos de Brito, Ana Caroline
    Alvarez-Pinzon, Natalia
    de Albergaria-Barbosa, Jose Ricardo
    INTERNATIONAL JOURNAL OF DENTISTRY, 2014, 2014
  • [28] The Predicting Factors of Bisphosphonate-related Osteonecrosis of the Jaw
    Universidade Fernando Pessoa
    1600,
  • [29] Treatment for bisphosphonate-related osteonecrosis of the jawQuestion: What is the best treatment for bisphosphonate-related osteonecrosis of the jaw (BRONJ)?
    Silvia Spivakovsky
    Evidence-Based Dentistry, 2017, 18 (2) : 56 - 56
  • [30] Bisphosphonate-Related Osteonecrosis of the Jaw: Role of MRI
    Filonzi, G.
    Bazzocchi, A.
    Spinnato, P.
    Ciccarese, F.
    Baglivo, E.
    Salizzoni, E.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 198 (05)
12345